LUNGMAP: A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)

Protocol No

SWOG-LUNGMAP

Staff Member

Jonathan Thompson

Phase

II/III

Summary

We are asking you to take part in this research study because you have non-small cell lung cancer. We are asking you to submit your tumor sample to test for specific genes and proteins. Based on the test results, you will be assigned to one of the treatment sub-studies.

Objective

Targeted Treatment for Advanced Non-Small Cell Lung Cancer

Study Sites

Froedtert West Bend Hospital Froedtert Menomonee Falls Hospital Froedtert Hospital

Status

OPEN TO ACCRUAL